NV Lab

M.D. Anderson Professor @UHEngineering.
Interested in cancer #immunotherapy, #vaccines, #immunology

[NV Lab @UH_NVLab]

Our lab works at the interface of engineering, immunology and immunotherapy.

https://t.co/WGJM4bvKQq

[NV Lab @UH_NVLab]

Our latest work was published in @HoustonChron!
University of Houston nasal vaccine prevents COVID from spreading : https://t.co/H8Cj7XNWg2

[Immunology of Infectious Disease News @infdisease_news]

Dr. Ankita Leekha from the @UH_NVLab led the development of NanoSTING 🦂, a nanoparticle formulation of the endogenous STING agonist, 2′−3′ cGAMP, to function as an immune activator and demonstrated its safety in mice and rats. 🐁 🐀

More here: https://t.co/bspSBG4m1e

[Katy Rezvani, M.D., Ph.D @lab_rezvani]

Many congratulations to our Dr. Sunil Acharya @sunilacharya13 for his exciting research on CD70-targeting CAR NK cells, published in Cancer Discovery! Sunil and his co-authors showed that the incorporation of CD28 costimulation, which is normally absent in NK cells, in the CAR construct improves efficacy of CAR NK cells via the LCK/CD3ζ/ZAP70 pathway. Sincere thanks to our collaborators for their invaluable contributions. We’re excited about the promising clinical trials ahead! @MDAndersonNews #CancerResearch #Immunotherapy #CAR_NKCells @kchenken @UH_NVLab

[Anirban Maitra @Aiims1742]

CD28 co-stimulation in NK cells? Who knew! New @CD_AACR paper from @lab_rezvani @MDAndersonNews showing CD28 costimulation can augment CAR signaling in mature NK cells via the LCK/CD3Z/ZAP70 axis.
https://t.co/aIZ8d2Bns6

[UH Media Relations @UH_News]

Team of #cancer researchers, led by @UHouston, discovered new #Tcells that may improve outcome for patients treated with T-cell therapies, especially those suffering from #lymphoma.
#lymphoma https://t.co/Epi6bf9F12

[NV Lab @UH_NVLab]

Latest UH press release featuring our new Nature Cancer paper! https://t.co/9PXIPuSwU8 @UHEngineering @UH_ChBE @UHouston

[Nature Cancer @NatureCancer]

Check out the latest articles @NatureCancer "Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling" https://t.co/45CYXfCjDA

[NV Lab @UH_NVLab]

Dynamic functional profiling of T-cell therapies uncover a subset of T cells, labeled CD8-fit, that are motile serial killers and are associated with clinical responses in diffuse B cell lymphoma patients.
https://t.co/xr9jHn8P1Z
(No Paywall) https://t.co/KSAVlNoPSK

[NV Lab @UH_NVLab]

An intranasal nanoparticle vaccine elicits protective immunity against Mycobacterium tuberculosis @UHEngineering @UH_ChBE https://t.co/hxE7amf9nY

[Daniela Robles @daniela-oaks.bsky.social @daniela_oaks]

Next - @UH_NVLab @MDAndersonNews @UHouston is telling us about the metabolic plasticity of T-cell Therapies, with an intriguing title, "digest more fat"! @MelanomaReAlli

[NV Lab @UH_NVLab]

Understanding redundancies in cytotoxic mechanisms employed by CAR T cells in the killing of tumors @UHEngineering @UH_ChBE

Link: https://t.co/ukdHsjRwSJ

[UH Chemical and Biomolecular Engineering @UH_ChBE]

Congratulations to PhD candidate Melisa Montalvo (advisor: @UH_NVLab) in her first-placr poster award at the @SHPE National Convention!

[NV Lab @UH_NVLab]

Congratulations to @CellChorus for being announced as a 2023 Houston Innovation Awards finalist in the Life Science Business sector! #startups #innovation #AI #immunology @_danmeyer

Link: https://t.co/his7BaXg7Q

[NV Lab @UH_NVLab]

Trained neural network detects apoptotic bodies of human melanoma cells without fluorescent labeling
@UHEngineering @UH_ChBE #MachineLearning #Immunology

Link: https://t.co/TlyxVaZBe4

[Ramanan @krishnamoorti]

Celebrating the induction of four of my @UHouston colleagues as senior members of the National Academy of Inventors. Congratulations Navin Varadarajan, @tjmountziaris, James Briggs and Gomika Udugamasooriya

[NV Lab @UH_NVLab]

Linking extracellular vesicle (EV) secretion to metastasis at the single-cell level
@MohsenFathi1993 @UH_ChBE @iScience_CP

iScience article: https://t.co/XHor3oogvI

[Mammary Cell News @MammaryCell]

Dr. Navin Varadarajan's team (@UH_NVLab) at @UHouston developed a method to identify 🔎 signatures of #ExtracellularVesicle secretion in metastatic #BreastCancer through functional single-cell profiling.

More in @iScience_CP
💡 https://t.co/8vvWrpZb8A

[American Institute of Chemical Engineers (AIChE) @ChEnected]

New tech developed at @UHEngineering shows promise as a weapon against #lymphoma https://t.co/aj9EuM9NMa #nanotech

[UH Chemical and Biomolecular Engineering @UH_ChBE]

(1/2) This issue of #Parameters features stories on @UH_ChBE Prof. Gül Zerze's academic path; new grants for @UH_NVLab (immunotherapy) and @ekourent (diagnostics); an ASEE award for postdoc Dr. LeShorn Benjamin (with @dr_jah_director); awards for Profs. Anil Bhowmick, ...

[Katy Rezvani, M.D., Ph.D @lab_rezvani]

Incredibly proud of Ye Ethan Li for having his PhD project published in Nat Med. His paper shows that trogocytosis drives relapse post CAR NK therapy & that modulating NK signaling can improve CAR NK efficacy. Congratulations Ethan! @KenChen @UH_NVLab
https://t.co/Wtpc3dWtPG